Register for citation alerts

Vascular Access Conversation - IVUPDATE Podcast from IVTEAM

"Standardized operative and perioperative TIVAP implantation procedures provide excellent results and low explantation rate" Thiel et al (2022).
Preventing implantable port complications

Abstract:

Purpose: Since their invention 40 years ago, totally implantable venous-access ports (TIVAPs) have become indispensable in cancer treatment. The aim of our study was to analyze complications under standardized operative and perioperative procedures and to identify risk factors for premature port catheter explantation.

Methods: A total of 1008 consecutive TIVAP implantations were studied for success rate, perioperative, early, and late complications. Surgical, clinical, and demographic factors were analysed as potential risk factors for emergency port catheter explantation.

Results: Successful surgical TIVAP implantation was achieved in 1005/1008 (99.7%) cases. No intraoperative or perioperative complications occurred. A total of 32 early complications and 88 late complications were observed leading to explantation in 11/32 (34.4%) and 34/88 (38.6%) cases, respectively. The most common complications were infections in 4.7% followed by thrombosis in 3.6%. Parameters that correlated with unplanned TIVAP explantation were gender (port in situ: female 95% vs. male 91%, p = 0.01), underlying disease (breast cancer 97% vs. gastrointestinal 89%, p = 0.004), indication (chemotherapy 95% vs. combination of chemotherapy and parenteral nutrition 64%, p < 0.0001), and type of complication (infection 13.4% vs. TIVAP-related complication 54% and thrombosis 95%, p < 0.0001).

Conclusion: Standardized operative and perioperative TIVAP implantation procedures provide excellent results and low explantation rate.

Reference:

Thiel K, Kalmbach S, Maier G, Wichmann D, Schenk M, Königsrainer A, Thiel C. Standardized procedure prevents perioperative and early complications in totally implantable venous-access ports-a complication analysis of more than 1000 TIVAP implantations. Langenbecks Arch Surg. 2022 Sep 7. doi: 10.1007/s00423-022-02656-9. Epub ahead of print. PMID: 36070032.